Nasdaq

AnPac Bio Class III Medical Device Passes Extensive NMPA Registration Tests and Will Start Clinical Trial in Q1, 2022

PHILADELPHIA, Jan. 04, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a US and China-based biotechnology company focused on early cancer ...
Business Wire

Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit – ANVS

SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers of Annovis Bio, Inc. (NYSE: ANVS) securities between May 21, 2021 and July 28, 2021, inclusive (the “Class Period ...
Nasdaq

China’s NMPA Approved Starting of Registration Testing of AnPac Bio Class III Medical Device (For Lung Cancer Auxiliary Diagnosis Utility)

SAN JOSE, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United ...
Sacramento State University

Class Schedule

An intensive introductory course for non-majors who will take additional course work in biology or related disciplines, including the allied health sciences. Introduction to the biological sciences ...
Business Wire

Investors With Substantial Losses Have Opportunity to Lead the Sesen Bio, Inc. Class Action Lawsuit – SESN

SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers of Sesen Bio, Inc. (NASDAQ: SESN) securities between December 21, 2020 and August 17, 2021, inclusive (the “Class ...
Sacramento State University

Class Schedule

Introduction to properties of life and cells leading to genetic and biological diversity. Survey of biological diversity emphasizing variation leading to natural selection; introduction to ecological ...